Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Dario Altieri

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Living Beings

Mice

Disorders

Neoplasms

Anatomy

Physiology

Concepts & Ideas

Molecular Sequence Data

Genes & Molecular Sequences

Amino Acid Sequence

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
32
Plescia, Janet
10
Dohi, Takehiko
9
Languino, Lucia
9
Mesri, Mehdi
8
Li, F
8
Adida, C
7
Ambrosini, G
7
Marchisio, Pier Carlo
7
Wall, Nathan
6
Tognin, Simona
6
O'Connor, Daniel
6
Grossman, Douglas
6
Xia, Fang
5
Kang, Byoung Heon
4
Pober, Jordan

Sign-in to see all Coauthors

Publications

TOP 3
Kang B H; Altieri D C
Compartmentalized cancer drug discovery targeting mitochondrial Hsp90 chaperones.
Guha Minakshi; Altieri Dario C
Survivin as a global target of intrinsic tumor suppression networks.
Filion Tera M; Qiao Meng; Ghule Prachi N; Mandeville Matthew; van Wijnen Andre J; Stein Janet L; Lian Jane B; Altieri Dario C; Stein Gary S
Survival responses of human embryonic stem cells to DNA damage.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Dario Altieri (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Kang B H; Altieri D C
Compartmentalized cancer drug discovery targeting mitochondrial Hsp90 chaperones.
Oncogene 2009;28(42):3681-8.
2009: Guha Minakshi; Altieri Dario C
Survivin as a global target of intrinsic tumor suppression networks.
Cell cycle (Georgetown, Tex.) 2009;8(17):2708-10.
2009: Filion Tera M; Qiao Meng; Ghule Prachi N; Mandeville Matthew; van Wijnen Andre J; Stein Janet L; Lian Jane B; Altieri Dario C; Stein Gary S
Survival responses of human embryonic stem cells to DNA damage.
Journal of cellular physiology 2009;220(3):586-92.
2009: Altieri Dario C; Languino Lucia R; Lian Jane B; Stein Janet L; Leav Irwin; van Wijnen Andre J; Jiang Zhong; Stein Gary S
Prostate cancer regulatory networks.
Journal of cellular biochemistry 2009;107(5):845-52.
2009: Guha Minakshi; Plescia Janet; Leav Irwin; Li Jing; Languino Lucia R; Altieri Dario C
Endogenous tumor suppression mediated by PTEN involves survivin gene silencing.
Cancer research 2009;69(12):4954-8.
2009: Kang Byoung Heon; Plescia Janet; Song Ho Young; Meli Massimiliano; Colombo Giorgio; Beebe Kristin; Scroggins Bradley; Neckers Len; Altieri Dario C
Combinatorial drug design targeting multiple cancer signaling networks controlled by mitochondrial Hsp90.
The Journal of clinical investigation 2009;119(3):454-64.
2008: Luo Jianyuan; Altieri Dario C
SIRTing through breast cancer is just a survivin' game.
Molecular cell 2008;32(2):159-60.
2008: Altieri D C
New wirings in the survivin networks.
Oncogene 2008;27(48):6276-84.
2008: Jiang Yuying; Nishimura Wataru; Devor-Henneman Deborah; Kusewitt Donna; Wang Haijuan; Holloway Michael P; Dohi Takehiko; Sabo Edmond; Robinson Michael L; Altieri Dario C; Sharma Arun; Altura Rachel A
Postnatal expansion of the pancreatic beta-cell mass is dependent on survivin.
Diabetes 2008;57(10):2718-27.
2008: Xia Fang; Canovas Pedro M; Guadagno Thomas M; Altieri Dario C
A survivin-ran complex regulates spindle formation in tumor cells.
Molecular and cellular biology 2008;28(17):5299-311.
2008: Lee Connie W; Raskett Christopher M; Prudovsky Igor; Altieri Dario C
Molecular dependence of estrogen receptor-negative breast cancer on a notch-survivin signaling axis.
Cancer research 2008;68(13):5273-81.
2008: Xia Fang; Lee Connie W; Altieri Dario C
Tumor cell dependence on Ran-GTP-directed mitosis.
Cancer research 2008;68(6):1826-33.
2008: Ghosh Jagadish C; Dohi Takehiko; Kang Byoung Heon; Altieri Dario C
Hsp60 regulation of tumor cell apoptosis.
The Journal of biological chemistry 2008;283(8):5188-94.
2008: Altieri Dario C
Survivin, cancer networks and pathway-directed drug discovery.
Nature reviews. Cancer 2008;8(1):61-70.
2008: Lee Connie W; Simin Karl; Liu Qin; Plescia Janet; Guha Minakshi; Khan Ashraf; Hsieh Chung-Cheng; Altieri Dario C
A functional Notch-survivin gene signature in basal breast cancer.
Breast cancer research : BCR 2008;10(6):R97.
2007: Kang Byoung Heon; Plescia Janet; Dohi Takehiko; Rosa Jack; Doxsey Stephen J; Altieri Dario C
Regulation of tumor cell mitochondrial homeostasis by an organelle-specific Hsp90 chaperone network.
Cell 2007;131(2):257-70.
2007: Dohi Takehiko; Xia Fang; Altieri Dario C
Compartmentalized phosphorylation of IAP by protein kinase A regulates cytoprotection.
Molecular cell 2007;27(1):17-28.
2007: Vaira V; Lee C W; Goel H L; Bosari S; Languino L R; Altieri D C
Regulation of survivin expression by IGF-1/mTOR signaling.
Oncogene 2007;26(19):2678-84.
2007: Nagaraj Srinivas; Pisarev Vladimir; Kinarsky Leo; Sherman Simon; Muro-Cacho Carlos; Altieri Dario C; Gabrilovich Dmitry I
Dendritic cell-based full-length survivin vaccine in treatment of experimental tumors.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2007;30(2):169-79.
2006: Meli Massimiliano; Pennati Marzia; Curto Maria; Daidone Maria Grazia; Plescia Janet; Toba Sam; Altieri Dario C; Zaffaroni Nadia; Colombo Giorgio
Small-molecule targeting of heat shock protein 90 chaperone function: rational identification of a new anticancer lead.
Journal of medicinal chemistry 2006;49(26):7721-30.
2006: Ghosh Jagadish C; Dohi Takehiko; Raskett Christopher M; Kowalik Timothy F; Altieri Dario C
Activated checkpoint kinase 2 provides a survival signal for tumor cells.
Cancer research 2006;66(24):11576-9.
2006: Altieri Dario C
The case for survivin as a regulator of microtubule dynamics and cell-death decisions.
Current opinion in cell biology 2006;18(6):609-15.
2006: Gyurkocza Boglarka; Plescia Janet; Raskett Christopher M; Garlick David S; Lowry Philip A; Carter Bing Z; Andreeff Michael; Meli Massimiliano; Colombo Giorgio; Altieri Dario C
Antileukemic activity of shepherdin and molecular diversity of hsp90 inhibitors.
Journal of the National Cancer Institute 2006;98(15):1068-77.
2006: Kang Byoung Heon; Altieri Dario C
Regulation of survivin stability by the aryl hydrocarbon receptor-interacting protein.
The Journal of biological chemistry 2006;281(34):24721-7.
2006: Decker William K; Qiu Jianxia; Farhangfar Farhang; Hester Jenny H; Altieri Dario C; Lin Augustine Y
A retrogen plasmid-based vaccine generates high titer antibody responses against the autologous cancer antigen survivin and demonstrates anti-tumor efficacy.
Cancer letters 2006;237(1):45-55.
2006: Conte Michael S; Altieri Dario C
Survivin regulation of vascular injury.
Trends in cardiovascular medicine 2006;16(4):114-7.
2006: Yang Shangxin; Lim Minyoung; Pham Linda K; Kendall Stephen E; Reddi A Hari; Altieri Dario C; Roy-Burman Pradip
Bone morphogenetic protein 7 protects prostate cancer cells from stress-induced apoptosis via both Smad and c-Jun NH2-terminal kinase pathways.
Cancer research 2006;66(8):4285-90.
2006: Xia Fang; Altieri Dario C
Mitosis-independent survivin gene expression in vivo and regulation by p53.
Cancer research 2006;66(7):3392-5.
2006: Dohi Takehiko; Salz Whitney; Costa Marco; Ariyan Charlotte; Basadonna Giacomo P; Altieri Dario C
Inhibition of apoptosis by survivin improves transplantation of pancreatic islets for treatment of diabetes in mice.
EMBO reports 2006;7(4):438-43.
2006: Altieri Dario C
Targeted therapy by disabling crossroad signaling networks: the survivin paradigm.
Molecular cancer therapeutics 2006;5(3):478-82.
2006: Rosa Jack; Canovas Pedro; Islam Ashraful; Altieri Dario C; Doxsey Stephen J
Survivin modulates microtubule dynamics and nucleation throughout the cell cycle.
Molecular biology of the cell 2006;17(3):1483-93.
2005: Wang Grace J; Sui Xin Xin; Simosa Hector F; Jain Mukesh K; Altieri Dario C; Conte Michael S
Regulation of vein graft hyperplasia by survivin, an inhibitor of apoptosis protein.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(10):2081-7.
2005: Ghosh Jagadish C; Altieri Dario C
Activation of p53-dependent apoptosis by acute ablation of glycogen synthase kinase-3beta in colorectal cancer cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(12):4580-8.
2005: McMurtry M Sean; Archer Stephen L; Altieri Dario C; Bonnet Sebastien; Haromy Alois; Harry Gwyneth; Bonnet Sandra; Puttagunta Lakshmi; Michelakis Evangelos D
Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension.
The Journal of clinical investigation 2005;115(6):1479-91.
2005: Altieri Dario C
T cell expansion: the survivin interface between cell proliferation and cell death.
Immunity 2005;22(5):534-5.
2005: Plescia Janet; Salz Whitney; Xia Fang; Pennati Marzia; Zaffaroni Nadia; Daidone Maria Grazia; Meli Massimiliano; Dohi Takehiko; Fortugno Paola; Nefedova Yulia; Gabrilovich Dmitry I; Colombo Giorgio; Altieri Dario C
Rational design of shepherdin, a novel anticancer agent.
Cancer cell 2005;7(5):457-68.
2005: Salz Whitney; Eisenberg Dan; Plescia Janet; Garlick David S; Weiss Robert M; Wu Xue-Ru; Sun Tung-Tien; Altieri Dario C
A survivin gene signature predicts aggressive tumor behavior.
Cancer research 2005;65(9):3531-4.
2005: Simosa Hector F; Wang Grace; Sui XinXin; Peterson Timothy; Narra Vinod; Altieri Dario C; Conte Michael S
Survivin expression is up-regulated in vascular injury and identifies a distinct cellular phenotype.
Journal of vascular surgery : official publication, the Society for Vascular Surgery [and] International Society for Cardiovascular Surgery, North American Chapter 2005;41(4):682-90.
2005: Wu Jianguo; Ling Xiang; Pan Dalin; Apontes Pasha; Song Lei; Liang Ping; Altieri Dario C; Beerman Terry; Li Fengzhi
Molecular mechanism of inhibition of survivin transcription by the GC-rich sequence-selective DNA binding antitumor agent, hedamycin: evidence of survivin down-regulation associated with drug sensitivity.
The Journal of biological chemistry 2005;280(10):9745-51.
2005: Lubet Ronald A; Huebner Kay; Fong Louise Y Y; Altieri Dario C; Steele Vernon E; Kopelovich Levy; Kavanaugh Claudine; Juliana M Margaret; Soong Seng-Jaw; Grubbs Clinton J
4-Hydroxybutyl(butyl)nitrosamine-induced urinary bladder cancers in mice: characterization of FHIT and survivin expression and chemopreventive effects of indomethacin.
Carcinogenesis 2005;26(3):571-8.
2005: Dohi Takehiko; Altieri Dario C
Mitochondrial dynamics of survivin and "four dimensional" control of tumor cell apoptosis.
Cell cycle (Georgetown, Tex.) 2005;4(1):21-3.
2004: Dohi Takehiko; Beltrami Elena; Wall Nathan R; Plescia Janet; Altieri Dario C
Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis.
The Journal of clinical investigation 2004;114(8):1117-27.
2004: Dohi Takehiko; Okada Kazuya; Xia Fang; Wilford Casey E; Samuel Temesgen; Welsh Kate; Marusawa Hiroyouki; Zou Hua; Armstrong Robert; Matsuzawa Shu-ichi; Salvesen Guy S; Reed John C; Altieri Dario C
An IAP-IAP complex inhibits apoptosis.
The Journal of biological chemistry 2004;279(33):34087-90.
2004: Altieri Dario C
Molecular circuits of apoptosis regulation and cell division control: the survivin paradigm.
Journal of cellular biochemistry 2004;92(4):656-63.
2004: Altieri Dario C
Profiles and legacies in cancer biology.
Cancer biology & therapy 2004;3(5):482-4.
2004: Altieri Dario C
Coupling apoptosis resistance to the cellular stress response: the IAP-Hsp90 connection in cancer.
Cell cycle (Georgetown, Tex.) 2004;3(3):255-6.
2004: Kirkiles-Smith Nancy C; Mahboubi Keyvan; Plescia Janet; McNiff Jennifer M; Karras James; Schechner Jeffrey S; Altieri Dario C; Pober Jordan S
IL-11 protects human microvascular endothelium from alloinjury in vivo by induction of survivin expression.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(3):1391-6.
2004: Beltrami Elena; Plescia Janet; Wilkinson John C; Duckett Colin S; Altieri Dario C
Acute ablation of survivin uncovers p53-dependent mitotic checkpoint functions and control of mitochondrial apoptosis.
The Journal of biological chemistry 2004;279(3):2077-84.
2003: Pisarev Vladimir; Yu Bin; Salup Raoul; Sherman Simon; Altieri Dario C; Gabrilovich Dmitry I
Full-length dominant-negative survivin for cancer immunotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(17):6523-33.
2003: Fornaro Mara; Plescia Janet; Chheang Sophie; Tallini Giovanni; Zhu Yong-M; King Michael; Altieri Dario C; Languino Lucia R
Fibronectin protects prostate cancer cells from tumor necrosis factor-alpha-induced apoptosis via the AKT/survivin pathway.
The Journal of biological chemistry 2003;278(50):50402-11.
2003: Altieri Dario C
Survivin, versatile modulation of cell division and apoptosis in cancer.
Oncogene 2003;22(53):8581-9.
2003: Fortugno Paola; Beltrami Elena; Plescia Janet; Fontana Jason; Pradhan Deepti; Marchisio Pier Carlo; Sessa William C; Altieri Dario C
Regulation of survivin function by Hsp90.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(24):13791-6.
2003: Kim Paul J; Plescia Janet; Clevers Hans; Fearon Eric R; Altieri Dario C
Survivin and molecular pathogenesis of colorectal cancer.
Lancet 2003;362(9379):205-9.
2003: Blanc-Brude Olivier P; Mesri Mehdi; Wall Nathan R; Plescia Janet; Dohi Takehiko; Altieri Dario C
Therapeutic targeting of the survivin pathway in cancer: initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(7):2683-92.
2003: Hausladen Derek A; Wheeler Marcia A; Altieri Dario C; Colberg John W; Weiss Robert M
Effect of intravesical treatment of transitional cell carcinoma with bacillus Calmette-Guerin and mitomycin C on urinary survivin levels and outcome.
The Journal of urology 2003;170(1):230-4.
2003: Allen Sarah M; Florell Scott R; Hanks Adrianne N; Alexander April; Diedrich Miyoung J; Altieri Dario C; Grossman Douglas
Survivin expression in mouse skin prevents papilloma regression and promotes chemical-induced tumor progression.
Cancer research 2003;63(3):567-72.
2003: Wall Nathan R; O'Connor Daniel S; Plescia Janet; Pommier Yves; Altieri Dario C
Suppression of survivin phosphorylation on Thr34 by flavopiridol enhances tumor cell apoptosis.
Cancer research 2003;63(1):230-5.
2003: Altieri Dario C
Validating survivin as a cancer therapeutic target.
Nature reviews. Cancer 2003;3(1):46-54.
2003: Altieri Dario C
Survivin in apoptosis control and cell cycle regulation in cancer.
Progress in cell cycle research 2003;5():447-52.
2003: Altieri Dario C
Blocking survivin to kill cancer cells.
Methods in molecular biology (Clifton, N.J.) 2003;223():533-42.
2003: Altieri Dario C
Survivin and apoptosis control.
Advances in cancer research 2003;88():31-52.
2002: Blanc-Brude Olivier P; Yu Jun; Simosa Hector; Conte Michael S; Sessa William C; Altieri Dario C
Inhibitor of apoptosis protein survivin regulates vascular injury.
Nature medicine 2002;8(9):987-94.
2002: O'Connor Daniel S; Wall Nathan R; Porter Andrew C G; Altieri Dario C
A p34(cdc2) survival checkpoint in cancer.
Cancer cell 2002;2(1):43-54.
2002: Griffith Thomas S; Fialkov Jonathan M; Scott David L; Azuhata Takeo; Williams Richard D; Wall Nathan R; Altieri Dario C; Sandler Anthony D
Induction and regulation of tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand-mediated apoptosis in renal cell carcinoma.
Cancer research 2002;62(11):3093-9.
2002: Giodini Alessandra; Kallio Marko J; Wall Nathan R; Gorbsky Gary J; Tognin Simona; Marchisio Pier Carlo; Symons Marc; Altieri Dario C
Regulation of microtubule stability and mitotic progression by survivin.
Cancer research 2002;62(9):2462-7.
2002: Fortugno Paola; Wall Nathan R; Giodini Alessandra; O'Connor Daniel S; Plescia Janet; Padgett Karen M; Tognin Simona; Marchisio Pier Carlo; Altieri Dario C
Survivin exists in immunochemically distinct subcellular pools and is involved in spindle microtubule function.
Journal of cell science 2002;115(Pt 3):575-85.
2002: Sharp Jennifer D; Hausladen Derek A; Maher M Grey; Wheeler Marcia A; Altieri Dario C; Weiss Robert M
Bladder cancer detection with urinary survivin, an inhibitor of apoptosis.
Frontiers in bioscience : a journal and virtual library 2002;7():e36-41.
2001: Altieri D C
The molecular basis and potential role of survivin in cancer diagnosis and therapy.
Trends in molecular medicine 2001;7(12):542-7.
2001: Grossman D; Kim P J; Blanc-Brude O P; Brash D E; Tognin S; Marchisio P C; Altieri D C
Transgenic expression of survivin in keratinocytes counteracts UVB-induced apoptosis and cooperates with loss of p53.
The Journal of clinical investigation 2001;108(7):991-9.
2001: Mesri M; Wall N R; Li J; Kim R W; Altieri D C
Cancer gene therapy using a survivin mutant adenovirus.
The Journal of clinical investigation 2001;108(7):981-90.
2001: Altieri D C
Statins' benefits begin to sprout.
The Journal of clinical investigation 2001;108(3):365-6.
2001: Mesri M; Morales-Ruiz M; Ackermann E J; Bennett C F; Pober J S; Sessa W C; Altieri D C
Suppression of vascular endothelial growth factor-mediated endothelial cell protection by survivin targeting.
The American journal of pathology 2001;158(5):1757-65.
2001: Carter B Z; Milella M; Altieri D C; Andreeff M
Cytokine-regulated expression of survivin in myeloid leukemia.
Blood 2001;97(9):2784-90.
2001: Mahboubi K; Li F; Plescia J; Kirkiles-Smith N C; Mesri M; Du Y; Carroll J M; Elias J A; Altieri D C; Pober J S
Interleukin-11 up-regulates survivin expression in endothelial cells through a signal transducer and activator of transcription-3 pathway.
Laboratory investigation; a journal of technical methods and pathology 2001;81(3):327-34.
2001: Smith S D; Wheeler M A; Plescia J; Colberg J W; Weiss R M; Altieri D C
Urine detection of survivin and diagnosis of bladder cancer.
JAMA : the journal of the American Medical Association 2001;285(3):324-8.
2001: Grossman D; Kim P J; Schechner J S; Altieri D C
Inhibition of melanoma tumor growth in vivo by survivin targeting.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(2):635-40.
2001: Grossman D; Altieri D C
Drug resistance in melanoma: mechanisms, apoptosis, and new potential therapeutic targets.
Cancer metastasis reviews 2001;20(1-2):3-11.
2000: O'Connor D S; Grossman D; Plescia J; Li F; Zhang H; Villa A; Tognin S; Marchisio P C; Altieri D C
Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(24):13103-7.
2000: Adida C; Recher C; Raffoux E; Daniel M T; Taksin A L; Rousselot P; Sigaux F; Degos L; Altieri D C; Dombret H
Expression and prognostic significance of survivin in de novo acute myeloid leukaemia.
British journal of haematology 2000;111(1):196-203.
2000: Adida C; Haioun C; Gaulard P; Lepage E; Morel P; Briere J; Dombret H; Reyes F; Diebold J; Gisselbrecht C; Salles G; Altieri D C; Molina T J
Prognostic significance of survivin expression in diffuse large B-cell lymphomas.
Blood 2000;96(5):1921-5.
2000: Papapetropoulos A; Fulton D; Mahboubi K; Kalb R G; O'Connor D S; Li F; Altieri D C; Sessa W C
Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway.
The Journal of biological chemistry 2000;275(13):9102-5.
2000: Li F; Flanary P L; Altieri D C; Dohlman H G
Cell division regulation by BIR1, a member of the inhibitor of apoptosis family in yeast.
The Journal of biological chemistry 2000;275(10):6707-11.
2000: Craig A; Fernandez-Reyes D; Mesri M; McDowall A; Altieri D C; Hogg N; Newbold C
A functional analysis of a natural variant of intercellular adhesion molecule-1 (ICAM-1Kilifi).
Human molecular genetics 2000;9(4):525-30.
2000: O'Connor D S; Schechner J S; Adida C; Mesri M; Rothermel A L; Li F; Nath A K; Pober J S; Altieri D C
Control of apoptosis during angiogenesis by survivin expression in endothelial cells.
The American journal of pathology 2000;156(2):393-8.
1999: Grossman D; McNiff J M; Li F; Altieri D C
Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma.
The Journal of investigative dermatology 1999;113(6):1076-81.
1999: Li F; Ackermann E J; Bennett C F; Rothermel A L; Plescia J; Tognin S; Villa A; Marchisio P C; Altieri D C
Pleiotropic cell-division defects and apoptosis induced by interference with survivin function.
Nature cell biology 1999;1(8):461-6.
1999: Li F; Altieri D C
Transcriptional analysis of human survivin gene expression.
The Biochemical journal 1999;344 Pt 2():305-11.
1999: Altieri D C; Marchisio P C;
Survivin apoptosis: an interloper between cell death and cell proliferation in cancer.
Laboratory investigation; a journal of technical methods and pathology 1999;79(11):1327-33.
1999: Altieri D C
Paracrine control of endothelial cell survival.
The Journal of clinical investigation 1999;104(7):845.
1999: Grossman D; McNiff J M; Li F; Altieri D C
Expression of the apoptosis inhibitor, survivin, in nonmelanoma skin cancer and gene targeting in a keratinocyte cell line.
Laboratory investigation; a journal of technical methods and pathology 1999;79(9):1121-6.
1999: Altieri D C
Regulation of leukocyte-endothelium interaction by fibrinogen.
Thrombosis and haemostasis 1999;82(2):781-6.
1999: Mesri M; Altieri D C
Leukocyte microparticles stimulate endothelial cell cytokine release and tissue factor induction in a JNK1 signaling pathway.
The Journal of biological chemistry 1999;274(33):23111-8.
1999: Li F; Altieri D C
The cancer antiapoptosis mouse survivin gene: characterization of locus and transcriptional requirements of basal and cell cycle-dependent expression.
Cancer research 1999;59(13):3143-51.
1998: Li F; Ambrosini G; Chu E Y; Plescia J; Tognin S; Marchisio P C; Altieri D C
Control of apoptosis and mitotic spindle checkpoint by survivin.
Nature 1998;396(6711):580-4.
1998: Mesri M; Altieri D C
Endothelial cell activation by leukocyte microparticles.
Journal of immunology (Baltimore, Md. : 1950) 1998;161(8):4382-7.
1998: Plescia J; Conte M S; VanMeter G; Ambrosini G; Altieri D C
Molecular identification of the cross-reacting epitope on alphaM beta2 integrin I domain recognized by anti-alphaIIb beta3 monoclonal antibody 7E3 and its involvement in leukocyte adherence.
The Journal of biological chemistry 1998;273(32):20372-7.
1998: Ambrosini G; Adida C; Sirugo G; Altieri D C
Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting.
The Journal of biological chemistry 1998;273(18):11177-82.
1998: Papapetropoulos A; Piccardoni P; Cirino G; Bucci M; Sorrentino R; Cicala C; Johnson K; Zachariou V; Sessa W C; Altieri D C
Hypotension and inflammatory cytokine gene expression triggered by factor Xa-nitric oxide signaling.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(8):4738-42.
1998: Adida C; Berrebi D; Peuchmaur M; Reyes-Mugica M; Altieri D C
Anti-apoptosis gene, survivin, and prognosis of neuroblastoma.
Lancet 1998;351(9106):882-3.
1998: Rothermel A L; Altieri D C
High affinity cross-reacting mAb generated by minimal mimicry: implications for the pathogenesis of anti-nuclear autoantibodies and immunosuppression.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(7):3816-20.
1998: Mesri M; Plescia J; Altieri D C
Dual regulation of ligand binding by CD11b I domain. Inhibition of intercellular adhesion and monocyte procoagulant activity by a factor X-derived peptide.
The Journal of biological chemistry 1998;273(2):744-8.
1998: Adida C; Crotty P L; McGrath J; Berrebi D; Diebold J; Altieri D C
Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation.
The American journal of pathology 1998;152(1):43-9.
1997: Ambrosini G; Adida C; Altieri D C
A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma.
Nature medicine 1997;3(8):917-21.
1997: Ambrosini G; Plescia J; Chu K C; High K A; Altieri D C
Activation-dependent exposure of the inter-EGF sequence Leu83-Leu88 in factor Xa mediates ligand binding to effector cell protease receptor-1.
The Journal of biological chemistry 1997;272(13):8340-5.
1997: Duperray A; Languino L R; Plescia J; McDowall A; Hogg N; Craig A G; Berendt A R; Altieri D C
Molecular identification of a novel fibrinogen binding site on the first domain of ICAM-1 regulating leukocyte-endothelium bridging.
The Journal of biological chemistry 1997;272(1):435-41.
1996: Plescia J; Altieri D C
Activation of Mac-1 (CD11b/CD18)-bound factor X by released cathepsin G defines an alternative pathway of leucocyte initiation of coagulation.
The Biochemical journal 1996;319 ( Pt 3)():873-9.
1996: Sriramarao P; Languino L R; Altieri D C
Fibrinogen mediates leukocyte-endothelium bridging in vivo at low shear forces.
Blood 1996;88(9):3416-23.
1996: Adida C; Ambrosini G; Plescia J; Crotty P L; Costa J; Altieri D C
Protease receptors in Hodgkin's disease: expression of the factor Xa receptor, effector cell protease receptor-1, in Reed-Sternberg cells.
Blood 1996;88(4):1457-64.
1996: Duchosal M A; Rothermel A L; McConahey P J; Dixon F J; Altieri D C
In vivo immunosuppression by targeting a novel protease receptor.
Nature 1996;380(6572):352-6.
1996: Ambrosini G; Altieri D C
Molecular dissection of effector cell protease receptor-1 recognition of factor Xa. Assignment of critical residues involved in antibody reactivity and ligand binding.
The Journal of biological chemistry 1996;271(2):1243-8.
1995: Almenar-Queralt A; Duperray A; Miles L A; Felez J; Altieri D C
Apical topography and modulation of ICAM-1 expression on activated endothelium.
The American journal of pathology 1995;147(5):1278-88.
1995: Altieri D C
Proteases and protease receptors in modulation of leukocyte effector functions.
Journal of leukocyte biology 1995;58(2):120-7.
1995: Altieri D C
Xa receptor EPR-1.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 1995;9(10):860-5.
1995: Languino L R; Duperray A; Joganic K J; Fornaro M; Thornton G B; Altieri D C
Regulation of leukocyte-endothelium interaction and leukocyte transendothelial migration by intercellular adhesion molecule 1-fibrinogen recognition.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(5):1505-9.
1995: Altieri D C
Leukocyte interaction with protein cascades in blood coagulation.
Current opinion in hematology 1995;2(1):41-6.
1995: Altieri D C; Duperray A; Plescia J; Thornton G B; Languino L R
Structural recognition of a novel fibrinogen gamma chain sequence (117-133) by intercellular adhesion molecule-1 mediates leukocyte-endothelium interaction.
The Journal of biological chemistry 1995;270(2):696-9.
1994: Zhou L; Lee D H; Plescia J; Lau C Y; Altieri D C
Differential ligand binding specificities of recombinant CD11b/CD18 integrin I-domain.
The Journal of biological chemistry 1994;269(25):17075-9.
1994: Altieri D C; Stamnes S J
Protease-dependent T cell activation: ligation of effector cell protease receptor-1 (EPR-1) stimulates lymphocyte proliferation.
Cellular immunology 1994;155(2):372-83.
1994: Altieri D C
Molecular cloning of effector cell protease receptor-1, a novel cell surface receptor for the protease factor Xa.
The Journal of biological chemistry 1994;269(5):3139-42.
1993: Languino L R; Plescia J; Duperray A; Brian A A; Plow E F; Geltosky J E; Altieri D C
Fibrinogen mediates leukocyte adhesion to vascular endothelium through an ICAM-1-dependent pathway.
Cell 1993;73(7):1423-34.
1993: Altieri D C
Coagulation assembly on leukocytes in transmembrane signaling and cell adhesion.
Blood 1993;81(3):569-79.
1993: Altieri D C; Plescia J; Plow E F
The structural motif glycine 190-valine 202 of the fibrinogen gamma chain interacts with CD11b/CD18 integrin (alpha M beta 2, Mac-1) and promotes leukocyte adhesion.
The Journal of biological chemistry 1993;268(3):1847-53.
1992: Altieri D C; Stamnes S J; Gahmberg C G
Regulated Ca2+ signalling through leukocyte CD11b/CD18 integrin.
The Biochemical journal 1992;288 ( Pt 2)():465-73.
1991: Altieri D C; Etingin O R; Fair D S; Brunck T K; Geltosky J E; Hajjar D P; Edgington T S
Structurally homologous ligand binding of integrin Mac-1 and viral glycoprotein C receptors.
Science (New York, N.Y.) 1991;254(5035):1200-2.
1991: Altieri D C
Occupancy of CD11b/CD18 (Mac-1) divalent ion binding site(s) induces leukocyte adhesion.
Journal of immunology (Baltimore, Md. : 1950) 1991;147(6):1891-8.
1990: Altieri D C; Edgington T S
Identification of effector cell protease receptor-1. A leukocyte-distributed receptor for the serine protease factor Xa.
Journal of immunology (Baltimore, Md. : 1950) 1990;145(1):246-53.
1990: Altieri D C; Agbanyo F R; Plescia J; Ginsberg M H; Edgington T S; Plow E F
A unique recognition site mediates the interaction of fibrinogen with the leukocyte integrin Mac-1 (CD11b/CD18).
The Journal of biological chemistry 1990;265(21):12119-22.
1990: Altieri D C; Wiltse W L; Edgington T S
Signal transduction initiated by extracellular nucleotides regulates the high affinity ligand recognition of the adhesive receptor CD11b/CD18.
Journal of immunology (Baltimore, Md. : 1950) 1990;145(2):662-70.
1989: Altieri D C; Edgington T S
Sequential receptor cascade for coagulation proteins on monocytes. Constitutive biosynthesis and functional prothrombinase activity of a membrane form of factor V/Va.
The Journal of biological chemistry 1989;264(5):2969-72.
1988: Altieri D C; Bader R; Mannucci P M; Edgington T S
Oligospecificity of the cellular adhesion receptor Mac-1 encompasses an inducible recognition specificity for fibrinogen.
The Journal of cell biology 1988;107(5):1893-900.
1988: Altieri D C; Morrissey J H; Edgington T S
Adhesive receptor Mac-1 coordinates the activation of factor X on stimulated cells of monocytic and myeloid differentiation: an alternative initiation of the coagulation protease cascade.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(20):7462-6.
1988: Altieri D C; Edgington T S
The saturable high affinity association of factor X to ADP-stimulated monocytes defines a novel function of the Mac-1 receptor.
The Journal of biological chemistry 1988;263(15):7007-15.

Sign-in to see more